“I prepared for my kids to grow up without me. Thanks to research, I am now cancer-free” Sophie Umhofer (pictured above), a mother of two, was diagnosed with stage four bowel cancer in 2018, aged 36.
What is the study about? IMPORT LOW investigates whether a more targeted type of radiotherapy for people with early breast cancer can reduce side effects without reducing how well the treatment works.
What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...
The ICR is an exempt charity – reference number X90004. We are also a member institution of the University of London and adhere to regulations as set by the Office for Students and Research England.
Thousands of men with prostate cancer in England will be offered a more precise form of radiotherapy that cuts treatment time by up to 75 per cent, based on the results of a trial led by The Institute ...
PENELOPE B is a phase III international, multicentre, randomised, placebo-controlled, double-blind trial comparing the efficacy and safety of adding palbociclib to standard hormone therapy vs standard ...
IMPORT HIGH is a phase III, prospective, randomised controlled trial to test whether dose escalated, intensity-modulated radiotherapy after conservation surgery for early breast cancer could reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results